Research Summary

Wang Z, Tang P, Xiao H, Peng S, Chen J, Wang Y, Xu J, Yan Q, Zhang J, Deng J, Ma Q, Zhu H, Luo W,   Zhang D, Wang L, Qin J, Lan W*, Jiang J*,   Liu   Q*. Histone demethylase PHF8 promotes prostate   cancer metastasis via the E2F1-SNAI1 axis.J Pathol . 2024 Sep;264(1):68-79.   doi: 10.1002/path.6325. Epub 2024 Jul 18.

Hanling Wang, Ni Li,Qiuli   Liu, Jiacheng Guo, Qiang Pan, Bisheng Cheng, Junyu Xu, Xuege Wang, Yongqiang Gu, Guoying Zhang, Yannan Lian, Wei Zhang, Mingyu Zhang, Tianyi Li, Yi Zang,   Minjia Tan, Qintong Li, Xiaoming Wang, Zhengquan Yu, Jun Jiang*, Hai Huang*, Jun Qin*. Antiandrogen   treatment induces stromal cell reprogramming to promote castration resistance   in prostate cancer.  Cancer Cell.  2023 Jul 10;41(7):1345-1362.e9.

Song Peng, Ze Wang, Peng Tang, Shuo Wang, Yiqiang Huang, Qiubo Xie, Yapeng Wang, Xintao Tan, Tang Tang, Xuzhi Yan, Jing Xu, Weihua Lan, Luofu Wang, Dianzheng Zhang, Bin Wang, Tiejun Pan, Jun Qin*, Jun Jiang*, and  Qiuli Liu*. PHF8-GLUL Axis in Lipid Deposition and Tumor Growth of Clear Cell Renal Cell Carcinoma. Sci Adv. 2023   Aug 2;9(31):eadf3566

Li N, Liu Q, Han Y, Pei S,   Cheng B, Xu J, Miao X, Pan Q, Wang H, Guo J, Wang X, Zhang G, Lian Y, Zhang   W, Zang Y, Tan M, Li Q, Wang X, Xiao Y, Hu G, Jiang J*, Huang H*, Qin J*. ARID1A loss induces polymorphonuclear   myeloid-derived suppressor cell chemotaxis and promotes prostate cancer   progression. Nat Commun. 2022 Nov 26;13(1):7281. 

Zhou L, Tang S, Li F, Wu   Y, Li S, Cui L, Luo J, Yang L, Ren Z, Zhang J, Zhou D, Jiang J*, Yang X*, Zhou X*, Wu Y*. Ceria nanoparticles   prophylactic used for renal ischemia-reperfusion injury treatment by   attenuating oxidative stress and inflammatory response. Biomaterials. 2022   Jul 18; 287:121686.

Tang S, Zhou L, He H, Cui   L, Ren Z, Tai Y, Xie Z, Cao Y, Meng D, Liu Q, Wu Y*, Jiang J*, Zhou X*. MnO2-melittin nanoparticles serve as an effective   anti-tumor immunotherapy by enhancing systemic immune response. Biomaterials.   2022 Sep; 288:121706.

Liu Q, Pang J, Wang LA,   Huang Z, Xu J, Yang X, Xie Q, Huang Y, Tang T, Tong D, Liu G, Wang L, Zhang   D, Ma Q, Xiao H, Lan W*, Qin J*, Jiang J*. Histone demethylase PHF8   drives neuroendocrine prostate cancer progression by epigenetically   upregulating FOXA2. J Pathol. 2021 Jan;253(1):106-118.

Yuan H, Han Y, Wang X, Li   N, Liu Q, Yin Y, Wang H, Pan L, Li L, Song K, Qiu T, Pan Q, Chen Q, Zhang G,   Zang Y, Tan M, Zhang J, Li Q, Wang X*, Jiang J*, Qin J*.  SETD2 Restricts   Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.. Cancer   Cell. 2020 Sep 14;38(3):350-365.

Liu Q, Tong D, Liu G, Gao   J, Wang LA, Xu J, Yang X, Xie Q, Huang Y, Pang J, Wang L, He Y, Zhang D, Ma   Q, Lan W*, Jiang J*. Metformin   Inhibits Prostate Cancer Progression by Targeting Tumor-Associated   Inflammatory Infiltration. Clin Cancer Res. 2018 Nov 15;24(22):5622-5634.